These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38153874)

  • 21. Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation.
    Wang F; Wu LM; Hua XL; Zhao ZZ; Chen XX; Xu JR
    J Magn Reson Imaging; 2018 Apr; 47(4):1054-1060. PubMed ID: 28815808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Woo S; Panebianco V; Narumi Y; Del Giudice F; Muglia VF; Takeuchi M; Ghafoor S; Bochner BH; Goh AC; Hricak H; Catto JWF; Vargas HA
    Eur Urol Oncol; 2020 Jun; 3(3):306-315. PubMed ID: 32199915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer.
    Elshetry ASF; El-Fawakry RM; Hamed EM; Metwally MI; Zaid NA
    Eur J Radiol; 2022 Jun; 151():110282. PubMed ID: 35381566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
    Panebianco V; Narumi Y; Altun E; Bochner BH; Efstathiou JA; Hafeez S; Huddart R; Kennish S; Lerner S; Montironi R; Muglia VF; Salomon G; Thomas S; Vargas HA; Witjes JA; Takeuchi M; Barentsz J; Catto JWF
    Eur Urol; 2018 Sep; 74(3):294-306. PubMed ID: 29755006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bladder MRI with deep learning-based reconstruction: a prospective evaluation of muscle invasiveness using VI-RADS.
    Zhang X; Wang Y; Xu X; Zhang J; Sun Y; Hu M; Wang S; Li Y; Chen Y; Zhao X
    Abdom Radiol (NY); 2024 May; 49(5):1615-1625. PubMed ID: 38652125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion.
    Wang H; Luo C; Zhang F; Guan J; Li S; Yao H; Chen J; Luo J; Chen L; Guo Y
    Radiology; 2019 Jun; 291(3):668-674. PubMed ID: 31012814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O; Gunduz N; Bakir B; Iplikci A; Culpan M; Ersoy B; Yildirim A
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F; Leonardo C; Simone G; Pecoraro M; De Berardinis E; Cipollari S; Flammia S; Bicchetti M; Busetto GM; Chung BI; Gallucci M; Catalano C; Panebianco V
    BJU Int; 2020 Nov; 126(5):610-619. PubMed ID: 32783347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pictorial review of multiparametric MRI in bladder urothelial carcinoma with variant histology: pearls and pitfalls.
    Arita Y; Woo S; Kwee TC; Shigeta K; Ueda R; Nalavenkata S; Edo H; Miyai K; Das J; Andrieu PIC; Vargas HA
    Abdom Radiol (NY); 2024 Aug; 49(8):2797-2811. PubMed ID: 38847848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field.
    Watanabe M; Taguchi S; Machida H; Tambo M; Takeshita Y; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Fukuhara H; Yokoyama K
    Eur Radiol; 2022 Nov; 32(11):7513-7521. PubMed ID: 35554648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study.
    Ikuma S; Akatsuka J; Takeda H; Endo Y; Kiriyama T; Hamasaki T; Kimura G; Kondo Y
    BMC Urol; 2024 Mar; 24(1):63. PubMed ID: 38509503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Akcay A; Yagci AB; Celen S; Ozlulerden Y; Turk NS; Ufuk F
    Clin Imaging; 2021 Sep; 77():25-36. PubMed ID: 33639497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting the muscle invasiveness of bladder cancer: An application of diffusion kurtosis imaging and tumor contact length.
    Li Q; Cao B; Liu K; Sun H; Ding Y; Yan C; Wu PY; Dai C; Rao S; Zeng M; Jiang S; Zhou J
    Eur J Radiol; 2022 Jun; 151():110329. PubMed ID: 35487092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Arita Y; Yoshida S; Shigeta K; Kwee TC; Edo H; Okawara N; Hashimoto M; Ishii R; Ueda R; Mikami S; Fujiwara M; Waseda Y; Kikuchi E; Fujii Y; Jinzaki M
    Eur Urol Oncol; 2023 Feb; 6(1):99-102. PubMed ID: 35933266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer.
    Kimura K; Yoshida S; Tsuchiya J; Kitazume Y; Waseda Y; Tanaka H; Yokoyama M; Toda K; Yoshimura R; Masaya I; Koga F; Tateishi U; Fujii Y
    Eur Radiol; 2023 Sep; 33(9):6245-6255. PubMed ID: 37045982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of accumulating experience on diagnostic performance of VI-RADS in bladder cancer.
    Gunduz N; Dogan MB; Kazan HO; Culpan M; Yıldırım A; Erdem G
    Clin Imaging; 2024 Oct; 114():110279. PubMed ID: 39241573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.